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The accurate assessment of immune competence through ex vivo analysis is paramount 
to our understanding of those immune mechanisms that lead to protection or suscepti-
bility against a broad range of human pathogens. We have developed a flow cytometry- 
based, whole blood phagocyte functional assay that utilizes the inflammatory inducer 
zymosan, coupled to OxyBURST-SE, a fluorescent reporter of phagosomal oxidase 
activity. The assay measures both phagocytic uptake and the superoxide burst in the 
phagocyte populations in whole blood. We utilized this assay to demonstrate impaired 
superoxide burst activity in the phagocytes of hospitalized HIV-positive patients with 
laboratory-confirmed tuberculosis. These data validate the use of the assay to assess the 
immune competence of patients in a clinical setting. The method is highly reproducible 
with minimal intraindividual variation and opens opportunities for the rapid assessment 
of cellular immune competence in peripheral blood in a disease setting.
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INtRodUCtIoN
Bacterial killing assays in whole blood are well established and allow ex vivo assessment of immune 
function in patients, particularly in the context of assessing response to vaccines or evaluating new 
bactericidal therapies (1–4). The main read out of these assays is microbial killing measured via 
culture and colony counting, or fluorescence if reporter strain organisms are used.
Potential problems of these microbiological killing assays include difficulties in standardizing 
the number of microbes and their multiplication rate. The tendency of the microbes to aggregate 
inconsistently during assays may also result in misrepresentation of the actual numbers of microbes 
measured at the end of the assay. In addition, there are other factors that can result in microbial loss 
that are not dependent on the host immune response or antimicrobial therapy (5). Finally, because 
the read out is simply bacterial survival, these assays lack the ability to differentiate mechanisms of 
killing and the relative contributions of the different phagocyte lineages present in the blood.
Phagocytosis is an important mechanism in the microbial killing pathway of phagocytes. 
Deficiencies in phagocyte function likely predispose individuals to acquire or succumb to infec-
tious diseases. An extensive range of dynamic assays of phagosome function have been developed 
that are capable of providing a broad range of physiological readouts from the phagosome (6, 7). 
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These assays have mostly utilized inert beads derivatized with 
different fluorescent reporters and focused on human alveolar 
macrophages or murine bone marrow-derived macrophages 
in culture (8–10). By removing cells from whole blood or their 
usual tissue fluid, we are unable to assess the potentially impor-
tant influence of soluble proteins such as cytokines, chemo-
kines, or antibodies on phagocytosis and phagosomal behavior. 
We therefore sought to develop an assay using a reporter particle 
more suitable for probing phagocyte biology in whole blood. 
The assay is designed to provide reproducible, unbiased, real-
time analysis of phagosomal function of immune cells and 
potentially identify patients with impaired immune responses.
We utilized zymosan derivatized with the oxidation-sensitive 
fluorescent reporter, OxyBURST-SE, to quantify phagosomal 
oxidase activity in peripheral blood phagocytes in situ. Zymosan 
is a preparation of a cell wall glucan from Saccharomyces cerevisiae 
that has been used as a model microbial particle in immune assays 
for over half a century (11). Zymosan is highly mannosylated 
and linked to β-glucan, making it susceptible to phagocytosis by 
monocytes, polymorphonuclear leukocytes, and macrophages 
through various receptors, including C-type lectin receptors 
such as dectin-1 and mannose receptors (12, 13). Phagocytosis 
of zymosan can occur independent of opsonization, of which 
complement factor 3 (C3) predominates with immunoglobulin 
G (IgG) being of minor importance (14). Zymosan also stimulates 
an inflammatory cytokine response via toll-like receptors (TLR) 
2 and 6, although activation of these receptors is not required for 
internalization by phagocytes (12). We had demonstrated previ-
ously how inert particles coupled to OxyBURST-SE can be used to 
quantify the superoxide bust of murine macrophages in vitro (15).
Superoxide burst is one of the key enzymatic activities 
involved in killing microbes during the process of phagocytosis. 
The generation of oxygen radicals via nicotinamide adenine 
dinucleotide phosphate (NADPH) oxidase leads to the pro-
duction of noxious compounds such as hydrogen peroxide 
with potent antimicrobial activity (16, 17). Superoxide burst’s 
importance is clearly demonstrated by the greatly increased risk 
of bacterial, fungal, and mycobacterial infection in patient with 
chronic granulomatous disease due to mutations in NADPH oxi-
dase (18). It has also been shown to be suppressed in individuals 
with HIV infection (19) and by Mycobacterium tuberculosis (TB) 
infection in vitro (20).
In this study, we report the application of this novel reporter 
platform to quantify the phagocytic and superoxide burst func-
tions of phagocytes in whole blood obtained from individuals in 
a clinical setting. First, we detail the information generated by 
application of the assay in whole blood from healthy controls. 
We then present data showing the utility of this assay in demon-
strating the perturbation of phagocyte function in the blood from 
HIV- and TB-coinfected patients in Malawi.
MAteRIALs ANd Methods
study Population
Adult patients with HIV and tuberculosis coinfection (HIV-TB) 
were recruited as part of a sub-study examining immune responses 
in the Malawi arm of the rapid urine-based screening for TB to 
reduce AIDS-related mortality in hospitalized patients in Africa 
(STAMP) (21). Healthy HIV-negative adults with no evidence 
of active TB were also recruited as controls. 5 ml of blood was 
collected from both patients and controls in sodium heparin 
tubes. All samples were processed and analyzed by flow cytom-
etry at the Malawi-Liverpool-Wellcome Trust Clinical Research 
Programme in Blantyre, Malawi within 2 h of blood draw. The 
study has been approved by the London School of Hygiene & 
Tropical Medicine Research Ethics Committee and the College 
of Medicine Research Ethics Committee, Malawi.
Zymosan Reporter Particles
To quantify both phagocytic activity and the magnitude of the 
superoxide burst we utilized zymosan particles coupled to both 
a calibration fluorochrome (Alexa Fluor 405-SE, Invitrogen) and 
an oxidation-sensitive fluorescent reporter (OxyBURST® Green 
H2DCFDA-SE, Invitrogen). Zymosan reporter particles were 
prepared by washing 6  mg of zymosan (Sigma-Aldrich) three 
times in 1× phosphate-buffered saline (PBS) by centrifugation 
at 10,000  rpm for 1  min. Particles were resuspended in 950  µl 
coupling buffer (0.1 M boric acid to pH 8.0 with NaOH) contain-
ing 10 µl of 25 mg/ml OxyBURST-SE/DMSO stock solution and 
5 µl of 5 mg/ml Alexa Fluor 405-SE/DMSO solution. The particles 
were mixed well and incubated on a tube rocker in the dark for 1 h 
at room temperature and washed with 1 ml of coupling buffer. The 
1 h coupling with OxyBURST-SE and calibration fluorochrome 
was repeated twice. Finally, particles were washed three times 
with PBS and stored in 1  ml of PBS containing 0.01% sodium 
azide in the dark at 4°C generating a final stock concentration of 
approximately 5 × 106 particles/ml.
Whole Blood Assay
Zymosan reporter particles were prepared for the whole blood 
assay by washing 50  µl of stock Zymosan particle suspensions 
three times with 1 ml of RPMI-1640 to remove sodium azide and 
resuspended in 250 µl RPMI-1640 to give a 1:6 dilution and a final 
concentration of approximately 8 × 105 particles/ml.
Whole blood was diluted 1:1 with warm RPMI-1640. 20 µl of 
washed and diluted reporter particles (containing approximately 
2 × 104 particles) were added to 1 ml of diluted blood and incu-
bated at 37°C with rocking to ensure particles and cells remain 
in suspension. Diluted blood without zymosan reporter particles 
was also processed in parallel as control. Phagocytosis of zymosan 
reporter particles and superoxide burst was assessed at 10, 30, 60, 
90, and 180 min after the addition of reporter particles.
100  µl of diluted blood was harvested from the zymosan 
reporter and biological control tubes 10  min before each time 
point for cell surface staining (as phagocytosis continues during 
cell surface staining of live cells). Once harvested, the diluted 
blood was stained with appropriately titrated concentrations 
of antibodies (anti-CD45 PerCP 1:33, anti-CD66b APC 1:50, 
and anti-CD14 PE-Cy7 1:100; all from BioLegend) for 10 min. 
Biological activity was arrested, red blood cells were lysed, and 
leukocytes fixed by adding 3  ml of BD FACS lysing solution 
(BD Biosciences), containing formaldehyde and diethylene gly-
col, to each tube and incubating at room temperature for 10 min. 
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The cells were washed once with 1× PBS by centrifugation at 
500 g for 10 min then resuspended in 500 µl 1× PBS. Counting 
beads (Countbright, Life Technologies) were added per the 
manufacturer’s instruction before acquisition on a CyAn ADP 
flow cytometer (Beckman Coulter, USA). The phagocytosis 
assay was performed in triplicate on the whole blood samples 
from healthy, HIV-negative adults. Data were analyzed using 
FlowJo version 10 (Treestar, USA).
In addition to the zymosan reporter assay, for HIV/TB- 
coinfected patients, immunophenotyping of monocytes in 
fresh whole blood was undertaken to investigate the association 
between monocyte phenotype and phagocytosis. In brief, 100 µl 
of fresh whole blood was stained with anti-CD45 Pacific Orange 
(Invitrogen), anti-HLA-DR PE-Cy7, anti-CD14 PE, and anti-
CD16 FITC (all from BioLegend) for 10  min. Red blood cells 
were lysed, and leukocytes fixed with BD FACS lysing solution, 
washed once with 1× PBS by centrifugation at 500 g for 10 min 
then resuspended in 300 µl PBS for flow cytometry acquisition.
electron Microscopy (eM)
In parallel, 2 ml of whole blood from a healthy HIV-negative con-
trol was incubated with approximately 8 × 104 zymosan reporter 
particles to confirm the zymosan particles were internalized by 
whole blood phagocytes. White blood cells were harvested after 
10, 60, and 180 min by centrifugation at 500 g for 10 min and 
carefully pipetting out the buffy coat layer in buffered glutaral-
dehyde fixative solution (2.5% glutaraldehyde in 0.1 M sodium 
cacodylate, 5 mM CaCl2, 5 mM MgCl2, 0.1 M sucrose, pH 7.2). 
The samples were processed and stained for EM as described 
previously (22).
Calculations and statistical Analysis
The proportion of cells that had phagocytosed reporter particles 
was calculated based on expression of calibration fluorochrome, 
and absolute cell numbers calculated using counting beads. 
An “activity index” of phagocytosis and superoxide burst was 
calculated by subtracting the median fluorescence intensity of 
the negative cells from the positive cells, and dividing this by 
two times the robust SD of the negative cells (23). This method 
accounted for variations in auto fluorescence between cells from 
different individuals.
Statistical analysis was performed using GraphPad Prism 7 
(GraphPad Software, USA) and Stata 11 (StataCorp, USA). Peak 
activity index (AI) was calculated and mean AI was compared 
between groups. The AI at each time point was also used to 
calculate the area under the curve. Means were compared using 
paired t-tests and median using Wilcoxon rank-sum.
ResULts/dIsCUssIoN
Zymosan Uptake by Whole Blood 
Phagocytes
We used whole blood from four healthy HIV-negative controls to 
measure phagocytosis and superoxide burst of phagocytes ex vivo 
using zymosan-reporter particles. We first sought to determine 
the kinetics of zymosan uptake by whole blood phagocytes. 
The flow cytometry gating strategy to identify neutrophils and 
monocytes is outlined in Figure 1. Cells that had phagocytosed 
zymosan-reporter particles were identified and quantified through 
measurement of the calibration fluor, Alexa Fluor 405.
Zymosan particles were avidly internalized by both neutro-
phils and monocytes in blood from healthy controls. Uptake was 
rapid, with a mean of 26% of neutrophils phagocytosing the par-
ticles compared with 12% of monocytes by 30 min (Figure 2A). 
The proportion of neutrophils phagocytosing zymosan did not 
increase substantially between 30 and 180 min, whereas the per-
centage of monocytes associated with zymosan-reporter particles 
increased gradually during the assay. This pattern of uptake was 
consistent across all healthy controls.
The uptake of zymosan reporter particles by both monocytes 
and neutrophils is dose dependent as shown in the dose–response 
curve generated for 0.5  ×  104–8  ×  104 zymosan particles/ml 
(Figure  2B). The abundance of the phagocytic cells in whole 
blood also influences the overall proportion of cells phagocytos-
ing zymosan particles (Figure 2C). The higher the concentration 
of cells, the lower the proportion of cells carrying the zymosan-
reporter signal, shown for both neutrophils and monocytes 
(Figures 2D,E). This relationship persists throughout the assay 
and demonstrates the importance of the phagocyte to particle ratio 
in the kinetics of phagocytosis. Relying solely on internalization 
of particles to assess phagocytic function is a potential limitation 
of the assay, as the magnitude of phagocytosis may be influenced 
by a function of cell concentration and/or cell to particle ratio, 
rather than cellular deficiencies in phagocytic capacity.
Electron microscopy of white blood cells from a healthy con-
trol whole blood incubated with zymosan particles demonstrates 
phagocytosis of zymosan particles by peripheral blood phago-
cytes (Figure 3). The EM images support the assumption that the 
zymosan reporter signal detected by flow cytometry originates 
from phagocytosis rather than the association of zymosan par-
ticles with the phagocyte surface. Almost without exception, the 
zymosan particles were observed inside the phagocyte.
Cell Loss Associated With Zymosan
To examine the effect of the zymosan particles on cell loss, we 
compared the samples containing zymosan reporter particles and 
control samples from the same healthy individuals. The mean 
concentration of neutrophils and monocytes declined during the 
assay more rapidly in the presence of zymosan than in control 
samples, with the largest decline occurring between 90 and 
180 min (Figures 4A,B).
Furthermore, the concentration of neutrophils associated 
with zymosan-reporter signal peaked at 60  min, followed by a 
decline (Figure 4A). By contrast, the concentration of zymosan-
associated monocytes plateaus at 30 min (Figure 4B). However, 
in both cell types the peak in zymosan uptake coincided with cell 
loss, suggesting that zymosan plays a role in inducing cell death. 
This is also supported by increased cell loss at higher concentra-
tions of zymosan in the assay (Figure 2B).
These observations are consistent with neutrophil and 
monocyte biology. Neutrophils are known to have a short half-
life in vitro, estimated to be 6–12 h, and do not proliferate (24). 
Programmed cell death of neutrophils occurs rapidly following 
FIGURe 1 | Gating strategy for identification of phagocytes with zymosan reporter particles and quantitation of intraphagosomal oxidation. (A) Gating strategy 
displaying forward scatter (FSC), side scatter (SSC), CD45 PerCP, CD66b APC, and CD14 PE-Cy7 to identify neutrophils and monocytes. The gating strategy 
illustrated is from one representative healthy volunteer. (B) Zymosan-induced superoxide burst activity in neutrophils and monocytes in a healthy control. The 
OxyBURST fluorescence increases after intraphagosomal oxidation of the zymosan-reporter particles (Alexa Fluor 405-labeled) after 10 and 60 min compared with 
control sample with no zymosan-reporter particles. (C) Overlay histogram demonstrating the shift in fluorescence of cells with zymosan reporter particles due to 
oxidation after 10 min (red), 30 min (orange), and 60 min (blue) compared with cells without zymosan-reporter particles (green) for both neutrophils and monocytes.
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phagocytosis of inflammatory particles, and reactive oxygen spe-
cies may be important triggers for induction of apoptosis (20). 
In neutrophils that have not phagocytosed zymosan particles, 
activation via direct binding of zymosan to TLR2 and TLR6 or in 
response to inflammatory cytokine and chemokine production 
may also contribute to cell death (12). By contrast, monocytes 
have an estimated half-life of <20 h in vivo, although this may be 
shorter ex vivo (25). Monocytes also undergo programmed cell 
death, unless they migrate to tissues and undergo differentiation 
into tissue macrophages (26). However, in contrast to neutrophils, 
inflammatory cytokine production and stimulation via TLR2 can 
promote survival by blocking programmed cell death (27). This 
may explain why monocytes that had phagocytosed zymosan 
reporter particles did not substantially decrease in number dur-
ing the assay.
Phagocytosis and superoxide Burst
Superoxide burst activity was measured at 10, 30, 60, 90, and 
180 min by comparing fluorescence of cells that had internalized 
zymosan reporter particles (calibration fluor-positive cells) with 
the cell population without zymosan (calibration fluor-negative 
cells) through measurement of the OxyBURST, superoxide sensor 
signal. The proportion of cells and intensity of superoxide reporter 
fluorescence increased over the time course of the assay in both 
FIGURe 2 | Phagocytosis of zymosan reporter particles by monocytes and neutrophils. (A) Proportion of cells that have phagocytosed zymosan over time using 
blood from healthy individuals incubated with approximately 2 × 104 zymosan particles/ml. Data represent mean values, and the error bars indicate SEM. 
Concentration of neutrophils (B) and monocytes (C) that have internalized zymosan reporter particles over time, with varying concentrations of particles. 
Relationship between the proportion of cells internalizing zymosan reporter particles (at an approximate concentration of 2 × 104 zymosan particles/ml) and absolute 
cell concentration for neutrophils (d) and monocytes (e) after 60 min. Each data point represents one sample from each individual done in triplicate. Four healthy 
volunteers in triplicate are shown in panels (A,d,e), and one health volunteer is shown in panels (B,C).
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monocytes and neutrophils (Figures 1B,C). The intensity of the 
calibration fluorochrome signal did not increase over time, sug-
gesting the increase in superoxide reporter signal was not due to 
cells internalizing greater numbers of zymosan-reporter particles 
but was specific to the oxidase activity (Figure 1B).
Both peripheral blood monocytes and neutrophils showed 
rapid oxidation within 30–60  min (Figures  4C,D). The kinet-
ics of oxidation in neutrophils and monocytes were similar to 
macrophages in other studies, with rapid oxidation before an 
equilibrium being reached, which likely represents cessation of 
NADPH oxidase activity (6, 15).
When the concentration of zymosan reporter particles was 
varied, the AI remained constant despite the concentration and 
proportion of cells taking up zymosan changing. This indicates 
the assay is able to measure physiological changes in the intensity 
and duration of phagocytosis and superoxide burst within the 
phagosome at an individual cell level. This is a significant advance 
over existing assays, which measure the extracellular accumula-
tion of products of oxidation that is dependent on the summation 
of phagocytosis and superoxide burst (28). Moreover, because 
this assay has cellular resolution, the relative contribution of the 
different phagocyte subsets can be accurately measured. We have 
also demonstrated that the assay is reproducible with minimal 
intraindividual variation.
Assays using OxyBURST coupled to IgG coated beads have 
previously been used to investigate oxidation within macrophage 
phagosomes (6, 15), and more recently in whole blood (29). The 
current assay exploiting zymosan as a reporter particle is an 
FIGURe 4 | Cell concentrations and activity index (AI) of superoxide burst over time. The concentration of neutrophils (A) and monocytes (B) at different time points 
from HIV-negative control samples without zymosan (green), and samples incubated with zymosan reporter beads that had internalized zymosan (blue) or did not 
internalize zymosan (red). In (C) neutrophils and (d) monocytes, each color represents the superoxide AI data from different individuals. The AIs are from four 
healthy, HIV-negative individuals, each performed in triplicate.
FIGURe 3 | Assessment of phagocytosis of zymosan reporter particles by 
electron microscopy. An electron micrograph illustrating zymosan particles (Z) 
inside a neutrophil 60 min post incubation of the reporter particles with whole 
blood. A red blood cell (R) can be seen to the right of the neutrophil. This 
image is representative and indicates that the zymosan particles are 
effectively internalized by cells in suspension. The scale bar = 1 µm.
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important addition to the range of phagocyte functional assays 
and offers considerable practical and technical advantages in 
the functional interrogation of whole blood direct from human 
subjects of interest.
Assessment of Whole Blood Phagocyte 
Function in Patients with hIV/tB 
Coinfection
The zymosan reporter assay was performed on blood samples 
obtained from 18 hospitalized HIV-positive patients with labora-
tory confirmed TB disease to compare phagocytic and superoxide 
respiratory burst activity in the phagosome between patients and 
healthy, HIV-negative, controls. The HIV/TB patients had a mean 
age of 41.4 years, a median CD4 cell count of 108.5 cells/mm3 
and 13/18 were taking antiretroviral therapy at the point of hos-
pital admission. The HIV/TB-coinfected patients demonstrated 
marked variation in phagosomal oxidation activity compared 
with healthy controls. The kinetics were similar to healthy 
controls with peak activity occurring at 30 min, although overall 
mean intensity of superoxide burst was significantly reduced 
throughout the assay (paired t-test, all p < 0.0001) (Figure 5A). 
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There was also a strong association between increased monocyte 
superoxide burst activity and the presence of a higher propor-
tion of “classical” CD14++CD16− monocytes (Figure 5B, linear 
regression coefficient 0.0014, 95% CI 0.0005–0.0024, p = 0.006). 
This association is consistent with the suggestion that classical 
monocytes are thought to specialize in phagocytosis compared 
with other monocyte subsets (30). However, the superoxide 
activity in monocytes was not related to the overall concentration 
of monocytes in patient’s blood (linear regression slope 0.0002, 
95% CI −0.0002 to 0.0005, p = 0.19), supporting the contention 
that the superoxide AI was not simply a function of phagocyte 
abundance.
These data demonstrate that the whole blood assay with 
zymosan reporter particles is a robust tool for assessing phago-
cyte function in a clinical setting. The time required to run the 
assay once the reporter particles have been made is minimal, 
with the processing of the sample through to acquisition by flow 
cytometry taking less than 4 h. We also demonstrated this assay 
can show marked differences between individuals and groups 
of patients based on clinical phenotype. It is interesting to note 
that the reduced superoxide burst in the phagocytes from HIV/
TB-coinfected individuals observed in this study is consistent 
with a recent report of impaired innate immune function of 
monocytes from HIV/TB-coinfected patient cohort in South 
Africa (31).
CoNCLUdING ReMARKs
We present a new method for studying whole blood phagocyte 
functional capacity ex vivo. This technique uses fluorescent-
tagged zymosan-reporter particles and whole blood, preserving, 
at least in part, the physiological in vivo conditions. It offers several 
advantages over standard microbiological killing assays because 
of its speed and simplicity, and its increased resolution whereby 
FIGURe 5 | Phagocytosis, superoxide burst, and monocyte phenotypes in peripheral blood phagocytes of HIV/tuberculosis (TB)-coinfected patients. (A) The 
superoxide burst activity index (AI) over time comparing cells from healthy individuals (blue) with cells from HIV/TB-coinfected patients (red). Lines represent means, 
and error bars are 95% CI. Mean AIs were lower in the HIV/TB patients at all time points analyzed (paired t-tests, all p < 0.0001). (B) The association between the 
proportion of HLA-DR+ monocytes that are CD14++CD16− (classical), CD14+CD16+ (intermediate), and CD14−CD16+ (non-classical), and monocyte phagocytosis 
and superoxide burst AI (measured as “area under the curve”). There is a strong association between higher proportions of classical monocytes and increased AI 
(p = 0.006) (n = 18). The data in panel (A) are from four health volunteers in triplicate, and the data in panel (B) are from 18 HIV/TB patients.
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